Royalties on Net Sales Value Sample Clauses

Royalties on Net Sales Value. The Licensee shall pay to the RPO a royalty of [●] per cent ([●]%) of the Net Sales Value of all Licensed Products, or any part thereof, sold or otherwise supplied by Licensee or its Affiliates.]
Sample 1Sample 2Sample 3See All (4)
AutoNDA by SimpleDocs
Royalties on Net Sales Value. The Licensee shall pay to Chroma a royalty of 5% (Five percent) of the Net Sales Value.
Sample 1Sample 2Sample 3
Royalties on Net Sales Value. 5.4.1 Orchard shall pay to UCLB during the Royalty Term, on a Gene Therapy Product by Gene Therapy Product basis, a royalty calculated as a particular Full Rate or Reduced Rate percentage of the Net Sales Value of the applicable Gene Therapy Product sold or disposed of by or on behalf of Orchard or its Sub-licensees, subject to the further provisions of this Clause 5 (a “Royalty”). Royalty payments shall be calculated by reference to the following percentage rates for the applicable Gene Therapy Product as follows: Gene Therapy Products Royalty Rate (as a % of Net Sales Value) Full Rate Reduced Rate ADA SCID Product [***] [***] Perforin Deficiency Product [***] [***] MPS1 Product [***] [***] [***] [***] [***] LCR-EFS Platform Product sold under a Marketing Approval where the indication does not include ADA-SCID, Perforin Deficiency, MPS1 or [***] [***] [***]
Sample 1Sample 2
Royalties on Net Sales Value. The Licensee shall pay to UCLB a royalty being a percentage of the Net Sales Value of all Licensed Products or any part thereof used, sold or disposed of by or on behalf of the Licensee or its Affiliates as follows:
Sample 1Sample 2
Royalties on Net Sales Value. The Licensee shall pay to the RPO a royalty of [●] per cent ([●]%) of the Net Sales Value of all Developed Products and Services, or any part thereof, sold or otherwise supplied by Licensee or its Affiliates. [Minimum royalties. If the royalties payable under Clause 4.3 are less than [●] Euro (€[●]) (“Minimum Royalty”) in any calendar year, the Licensee shall pay to the RPO the amount by which such royalties are less than the Minimum Royalty within sixty (60) days of the end of such calendar year, failing which the RPO shall be entitled to terminate this Agreement and all licences granted under this Agreement by notice in writing to the Licensee given at any time after the expiry of the said sixty (60) day period. If this Agreement ends on any day other than the end of a calendar year, the Minimum Royalty due for that year shall be reduced, pro-rata, i.e. the minimum amount due shall be the Minimum Royalty for a complete year multiplied by the number of days of the final calendar year during which this Agreement was in force, and divided by three hundred and sixty five (365) days.] Payment frequency. Royalties due under this Agreement shall be paid within thirty (30) days of the end of each quarter ending on 31 March, 30 June, 30 September and 31 December, in respect of sales and other supplies of Developed Products and Services made during such quarter and within thirty (30) days of the termination of this Agreement. Payment terms. All sums due under this Agreement: are exclusive of Value Added Tax which where applicable will be paid by the Licensee to the RPO in addition; shall be paid in Euro in cash by transferring an amount in aggregate to the following account number [●], sort code [●], account name [●], held with [●] Bank plc, [address]; shall be made without deduction of income tax or other taxes charges or duties that may be imposed, except insofar as the Licensee is required to deduct the same to comply with applicable laws. The Parties shall cooperate and take all steps reasonably and lawfully available to them, at the reasonable expense of the RPO, to avoid deducting such taxes and to obtain double taxation relief. If the Licensee is required to make any such deduction it shall provide the RPO with such certificates or other documents as it can reasonably obtain to enable the RPO to obtain appropriate relief from double taxation of the payment in question; and shall be made by the due date, failing which the RPO may charge interest on any outst...
Sample 1
Royalties on Net Sales Value. The Licensee shall pay to Volition a royalty of 5% of the Net Sales Value.
Sample 1
Royalties on Net Sales Value. The Licensee shall pay to ValiRx a royalty of 5% of the Net Sales Value.
Sample 1
AutoNDA by SimpleDocs
Royalties on Net Sales Value. The Licensee shall pay to Hypergenomics a royalty of 5% of the Net Sales Value.
Sample 1
Royalties on Net Sales Value. The Licensee shall pay to the University a royalty of [●] per cent ([●]%) of the Net Sales Value of all Licensed Products, or any part thereof, sold, licensed or otherwise supplied by Licensee or its Affiliates.
Sample 1

Related to Royalties on Net Sales Value

  • Royalties on Net Sales Novo will pay to Neose royalties as a percentage of annual Net Sales of each New Product during the Term at the applicable rates set forth in this Section 4.1 and in accordance with this Section 4:

  • Net Sales The term “

  • Royalty Rates On a Licensed Product-by-Licensed Product and country-by-country basis, during the Royalty Term, Imugene shall pay to Precision a royalty equal to the percentages of aggregate annual global Net Sales of such Licensed Product, as set forth below (the “Royalty”), calculated by multiplying the applicable royalty rate percentage by the corresponding portion of aggregate global Net Sales for such Licensed Product in such Calendar Year. For purposes of determining whether the Net Sales thresholds in the table below have been achieved for a Licensed Product, all Net Sales of such Licensed Product shall be aggregated globally for all sales made by Imugene or any of its Affiliates or its or their Sublicensees of such Licensed Product, in any and all preparations, formulations, dosages, packaging or methods of administration thereof. Annual Net Sales of the Applicable Licensed Product Royalty Rate Aggregate annual global Net Sales of an Existing Product less than [***] [***] Aggregate annual global Net Sales of an Existing Product equal to or greater than [***] but less than [***] [***] Aggregate annual global Net Sales of an Existing Product equal to or greater than [***] [***] Aggregate annual global Net Sales of an Additional Product less than [***] [***] Aggregate annual global Net Sales of an Additional Product equal to or greater than [***] but less than [***] [***] Aggregate annual global Net Sales of an Additional Product equal to or greater than [***] [***]

  • Royalty Rate Licensee shall pay to Licensor three percent (3%) of the first $25 million of Revenues received by Licensee or its Affiliates, and two percent (2%) of all additional Revenues received by Licensee or its Affiliates, subject to reductions pursuant to Sections 4.2.2 and 4.2.3.

  • Royalty Fees In further consideration of the distribution rights and related rights granted by Shengqu to the Licensees hereunder, the Licensees shall pay to Shengqu a royalty fee equal to 35% of revenues on a monthly basis.

  • Sublicense Revenue In the event Licensee or an Affiliate of Licensee sublicenses under Section 2.2, Licensee shall pay CareFusion **THE CONFIDENTIAL PORTION HAS BEEN SO OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND HAS BEEN FILED SEPARATELY WITH THE COMMISSION.** of any Sublicense Revenues resulting from sublicense agreements executed by Licensee.

  • Sublicense Income Company shall pay Medical School {***} of all Sublicense Income. Such amounts shall be due and payable within sixty (60) days after Company receives the relevant payment from the Sublicensee.

  • Sublicense Fees Licensee will pay Sublicense Fees indicated in Section 3.1(e) of the Patent & Technology License Agreement on or before the Quarterly Payment Deadline for the Contract Quarter.

  • Earned Royalties Subject to of Article 7 hereof, Licensee shall pay to Licensor for the rights granted hereunder a sum equal to one and [*****] of the Net Invoice Value of Trademarked Products Sold by Licensee (the "Royalties"). The Royalties shall be remitted in accordance with Section 7.4 of this Agreement. 6.2

  • Royalties 1. Royalties arising in a Contracting State and paid to a resident of the other Contracting State may be taxed in that other State.

Time is Money Join Law Insider Premium to draft better contracts faster.